[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352755-105":59,"doc-detail-352755-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","from-mechanism-to-clinical-research-evolution-and-hotspot-analysis-of-cd276b7-h3-in-cancer-immunotherapy","From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy","","CD276 (B7-H3) functions as a dual-role immune checkpoint molecule involved in T-cell regulation and tumor immune evasion. A systematic bibliometric study mapped the research landscape, evolutionary trends, and knowledge structure from January 2001 to August 2025 using 830 publications retrieved from Web of Science Core Collection and Scopus. Publication growth, leading countries, influential authors and institutions, and keyword evolution were assessed with Bibliometrix, VOSviewer, CiteSpace, and Pajek, highlighting a shift toward immunotherapy and CAR T-cell strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/from-mechanism-to-clinical-research-evolution-and-hotspot-analysis-of-cd276b7-h3-in-cancer-immunotherapy/352755/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/from-mechanism-to-clinical-research-evolution-and-hotspot-analysis-of-cd276b7-h3-in-cancer-immunotherapy/352755.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study on CD276/B7-H3?","Question",{"text":112,"@type":113},"The study analyzes how research on CD276/B7-H3 has evolved and identifies hotspot areas in cancer immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and timeframe were used to collect publications?",{"text":117,"@type":113},"Publications were systematically retrieved from Web of Science Core Collection and Scopus covering January 2001 to August 2025.",{"name":119,"@type":110,"acceptedAnswer":120},"What methodology supports the research trends and hotspot analysis?",{"text":121,"@type":113},"The analysis used Bibliometrix, VOSviewer, CiteSpace, and Pajek to evaluate publication trends, key contributors, collaboration networks, core journals, and keyword evolution.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352755,1792730715,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Systematic Review PUBLISHED 01 April 2026  \nDOI 10.3389/fimmu.2026.1751400  \nOPEN ACCESS  \nEDITED BY  \nRoberta Castriconi,  \nUniversity of Genoa, Italy  \nREVIEWED BY  \nAlessandra Dondero, University of Genoa, Italy Li Su,  \nLanzhou University, China  \n*CORRESPONDENCE  \nLeifeng Chen  \n[18770099029@126.com](18770099029@126.com)[ ](18770099029@126.com)Fan Zhou  \n [nczhoufan@126.com](nczhoufan@126.com)  \n†These authors have contributed equally to this work  \nRECEIVED 21 November 2025  \nREVISED 06 March 2026  \nACCEPTED 18 March 2026  \nPUBLISHED 01 April 2026  \nCITATION  \nZhai C, Ye J, Li X, Liu J, Zhou X, Wang Z, Zhang X, Zeng W, Luo H, Chen L and Zhou F (2026) From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy.  \nFront. Immunol. 17:1751400 .  \ndoi: 10.3389/fimmu.2026.1751400  \nCOPYRIGHT  \n© 2026 Zhai, Ye, Li, Liu, Zhou, Wang, Zhang, Zeng, Luo, Chen and Zhou. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nFrom mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy  \nChaojie Zhai 1,2†, Jiarong Ye 1,2†, Xiaoyan Li 3, Jipeng Liu 1,2, Xinchi Zhou 1,2, Zuao Wang 1,2, Xu Zhang 1,2,4, Wen Zeng 1,2,4, Hongliang Luo 1,2, Leifeng Chen 1,2,5,6* and Fan Zhou 1,2*  \n1 Department of General Surgery, The Second Afﬁliated Hospital of Nanchang University, Nanchang, Jiangxi, China, 2 Precision Oncology Medicine Center, The Second Afﬁliated Hospital of Nanchang University, Nanchang, Jiangxi, China, 3 Biobank Center, The Second Afﬁliated Hospital of Nanchang University, Nanchang, Jiangxi, China, 4 Department of Anesthesiology, The Second Afﬁliated Hospital of Nanchang University, Nanchang, Jiangxi, China, 5 Department of Oncology, The Second Afﬁliated Hospital of Nanchang University, Nanchang, Jiangxi, China, 6 Medical Center for Cardiovascular Diseases, Neurological Diseases and Tumors of Jiangxi Province, The Second Afﬁliated Hospital of Nanchang University, Nanchang, China  \nBackground: CD276 (B7-H3) is a pivotal immune checkpoint molecule with dual roles in T-cell regulation and tumor immune evasion, representing a promising therapeutic target across multiple cancers. However, a comprehensive analysis of the research landscape, evolutionary pathways, and knowledge structure in this ﬁeld remains lacking.  \nMethods: Publications related to CD276/B7-H3 in cancer research were systematically retrieved from the Web of Science Core Collection (WoS, n = 688) and Scopus (n = 759) spanning from January 2001 to August 2025 . After merging and de-duplication, a ﬁnal corpus of 830 publications was analyzed using Bibliometrix, VOSviewer, CiteSpace, and Pajek to evaluate publication trends, inﬂuential authors and institutions, collaboration networks, core journals, co-citation patterns, and keyword evolution.  \nResults: The ﬁeld exhibited exponential growth with an annual publication increase of 21 .77% . China and the United States were the dominant contributing countries. Journal for Immunotherapy of Cancer was the most productive journal, while Clinical Cancer Research produced the most impactful publications. Co-citation analysis highlighted foundational studies on B7-H3 ’s prognostic signiﬁcance and recent breakthroughs in CAR T-cell therapy targeting B7-H3 . Keyword evolution revealed a clear transition from early themes such as“ expression ” and “ prognosis ” to contemporary focuses including“immunotherapy,” “tumor microenvironment,” and “chimeric antigen receptor”. Conclusion: This study provides the ﬁrst integrated bibliometric overview of CD276/B7-H","cbCaifTs0o8V6Mei","https://ap.wps.com/l/cbCaifTs0o8V6Mei","pdf",4112267,21,"English","# Introduction\n## Background and rationale\n## CD276/B7-H3 in immunotherapy","[{\"question\":\"What is the main focus of the study on CD276/B7-H3?\",\"answer\":\"The study analyzes how research on CD276/B7-H3 has evolved and identifies hotspot areas in cancer immunotherapy.\"},{\"question\":\"Which databases and timeframe were used to collect publications?\",\"answer\":\"Publications were systematically retrieved from Web of Science Core Collection and Scopus covering January 2001 to August 2025.\"},{\"question\":\"What methodology supports the research trends and hotspot analysis?\",\"answer\":\"The analysis used Bibliometrix, VOSviewer, CiteSpace, and Pajek to evaluate publication trends, key contributors, collaboration networks, core journals, and keyword evolution.\"}]","From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy | PDF",1790101239,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bf1618c3d4473e0c145abcf8dd97092.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67c2b1f7265b4b03c935098d492f011d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75b7bc4f42c032e979f808e7bb6c39f1.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8c26202e7bb3bb49608ef0889d1b67b.webp",980,1385]